技术资料
-
文献Keller GM (DEC 1995) Current opinion in cell biology 7 6 862--9
In vitro differentiation of embryonic stem cells.
Under appropriate conditions in culture,embryonic stem cells will differentiate and form embryoid bodies that have been shown to contain cells of the hematopoietic,endothelial,muscle and neuronal lineages. Many aspects of the lineage-specific differentiation programs observed within the embryoid bodies reflect those found in the embryo,indicating that this model system provides access to early cell populations that develop in a normal fashion. Recent studies involving the differentiation of genetically altered embryonic stem cells highlight the potential of this in vitro differentiation system for defining the function of genes in early development. View Publication -
文献Yu J et al. (JAN 2011) PloS one 6 3 e17557
Efficient feeder-free episomal reprogramming with small molecules.
Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises,human iPSCs will ideally be free of exogenous DNA (footprint-free),and be derived and cultured in chemically defined media free of feeder cells. Currently,methods are available to enable efficient derivation of footprint-free human iPSCs. However,each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery,but the process was inefficient and required feeder cells. Here,we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901,GSK3β inhibitor CHIR99021,TGF-β/Activin/Nodal receptor inhibitor A-83-01,ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover,we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts,adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs. View Publication
过滤器
筛选结果
类别
- 教育资源
- Areas of Interest
- Methods Library
Show More
Show Less
研究领域
产品系列
- ES-Cult 1 项目
- MesenCult 1 项目
- TeSR 1 项目
Show More
Show Less
细胞类型
- B 细胞 134 项目
- CD4+ 84 项目
- CD8+ 48 项目
- CHO细胞 1 项目
- NK 细胞 79 项目
- PSC衍生 24 项目
- T 细胞 295 项目
- 上皮细胞 47 项目
- 乳腺细胞 68 项目
- 先天性淋巴细胞 3 项目
- 内皮细胞 2 项目
- 内胚层 1 项目
- 前列腺细胞 7 项目
- 多能干细胞 1692 项目
- 心肌细胞 3 项目
- 杂交瘤细胞 76 项目
- 树突状细胞(DCs) 59 项目
- 气道细胞 40 项目
- 癌细胞和细胞系 116 项目
- 白细胞单采样本 1 项目
- 白血病/淋巴瘤细胞 8 项目
- 监管 11 项目
- 真皮细胞 1 项目
- 神经元 136 项目
- 神经干/祖细胞 384 项目
- 神经细胞 19 项目
- 粒细胞及其亚群 61 项目
- 肝细胞 3 项目
- 肠道细胞 13 项目
- 肾脏细胞 2 项目
- 脑肿瘤干细胞 81 项目
- 血小板 1 项目
- 血浆 3 项目
- 调节性细胞 7 项目
- 造血干祖细胞 779 项目
- 间充质干祖细胞 133 项目
- 髓系细胞 99 项目
Show More
Show Less
资源类别
- 文献 2 项目
Show More
Show Less